| 1 (26) | AstraZeneca * | MUL |  |
| 2 (49) | Sanofi * | MUL | |
| 3 (62) | Pfizer * | MUL | |
| 4 (79) | F Hoffmann-La Roche * | MUL | |
| 5 (80) | Boehringer Ingelheim * | MUL | |
| 6 (84) | Johnson & Johnson * | MUL | |
| 7 (86) | Janssen Biotech Inc | USA | |
| 8 (87) | GlaxoSmithKline * | MUL | |
| 9 (90) | Janssen | MUL | |
| 10 (102) | Eli Lilly * | MUL | |
| 11 (112) | UCB Pharma SA * | MUL | |
| 12 (131) | GlaxoSmithKline, United Kingdom | GBR | |
| 13 (136) | Eli Lilly and Company, United States | USA | |
| 14 (141) | Pfizer Inc, United States | USA | |
| 15 (157) | GlaxoSmithKline, United States | USA | |
| 16 (169) | Boehringer Ingelheim GmbH Germany | DEU | |
| 17 (175) | UCB Pharma SA, Belgium | BEL | |
| 18 (197) | Gilead Sciences * | MUL | |
| 19 (199) | Bristol-Myers Squibb Company * | MUL | |
| 20 (201) | Novartis * | MUL | |
| 21 (204) | Bristol-Myers Squibb Company, United States | USA | |
| 22 (221) | Gilead Sciences Inc, United States | USA | |
| 23 (277) | Novartis, Switzerland | CHE | |
| 24 (293) | AbbVie * | MUL | |
| 25 (318) | Novartis Pharmaceuticals, United States | USA | |
| 26 (336) | AbbVie Inc, United States | USA | |
| 27 (485) | Amgen * | MUL | |
| 28 (504) | Pfizer Inc, United Kingdom | GBR | |
| 29 (738) | Amgen, USA | USA | |
|
